S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
Log in

OTCMKTS:ORINY - ORION OYJ/ADR Stock Price, Forecast & News

$20.78
0.00 (0.00 %)
(As of 12/30/2019)
Add
Compare
Today's Range
$20.78
Now: $20.78▼
$20.78
50-Day Range
$20.78
MA: $20.78▼
$20.78
52-Week Range
$18.73
Now: $20.78▼
$20.78
Volume81 shs
Average Volume4 shs
Market Capitalization$5.85 billion
P/E Ratio25.04
Dividend Yield3.17%
Beta0.58
Orion Oyj engages in the development and manufacture of pharmaceuticals, active pharmaceutical ingredients (APIs), and diagnostic tests worldwide. The company operates in two segments, Pharmaceuticals and Diagnostics. The Pharmaceuticals segment develops, manufactures, and markets pharmaceuticals and APIs. This segment provides proprietary drugs in the areas of central nervous system, oncology and critical care, and pulmonary care; generic prescription drugs, as well as self-care products, such as non-prescription medicines, basic ointments, and vitamins; proprietary and generic veterinary drugs; and APIs for generic and proprietary drugs, as well as offers contract manufacturing services for APIs. Read More…

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ORINY
Previous SymbolNASDAQ:ORINY
CUSIPN/A
CIKN/A
Webhttp://www.orion.fi/
Phone358 10 4261

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio25.04
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.15 billion
Price / Sales5.07
Cash Flow$1.00 per share
Price / Cash Flow20.79
Book Value$3.23 per share
Price / Book6.43

Profitability

EPS (Most Recent Fiscal Year)$0.83
Net Income$389.97 million
Net Margins17.50%
Return on Equity23.84%
Return on Assets14.72%

Miscellaneous

Employees3,179
Outstanding Shares281,480,000
Market Cap$5.85 billion
Next Earnings Date2/5/2020 (Estimated)
OptionableNot Optionable

Receive ORINY News and Ratings via Email

Sign-up to receive the latest news and ratings for ORINY and its competitors with MarketBeat's FREE daily newsletter.

OTC:ORINY Rates by TradingView

33% Gain While You Make Your Coffee (Ad)


What a cool story coming out of The War Room today.

One of the members made a trade on Bryan's recommendation... went to get a cup of coffee... and closed out a 33% win by the time he got back!

That's more than most people make in a year! You CANNOT miss out on these wins anymore.

ORION OYJ/ADR (OTCMKTS:ORINY) Frequently Asked Questions

What is ORION OYJ/ADR's stock symbol?

ORION OYJ/ADR trades on the OTCMKTS under the ticker symbol "ORINY."

How often does ORION OYJ/ADR pay dividends? What is the dividend yield for ORION OYJ/ADR?

ORION OYJ/ADR declared an annual dividend on Thursday, February 7th. Shareholders of record on Thursday, March 28th will be given a dividend of $0.669 per share on Friday, April 19th. This represents a yield of 3.91%. The ex-dividend date of this dividend is Wednesday, March 27th. View ORION OYJ/ADR's Dividend History.

When is ORION OYJ/ADR's next earnings date?

ORION OYJ/ADR is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for ORION OYJ/ADR.

Has ORION OYJ/ADR been receiving favorable news coverage?

News articles about ORINY stock have trended very negative on Friday, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. ORION OYJ/ADR earned a daily sentiment score of -3.6 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for ORION OYJ/ADR.

Who are some of ORION OYJ/ADR's key competitors?

What other stocks do shareholders of ORION OYJ/ADR own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ORION OYJ/ADR investors own include Agile Therapeutics (AGRX), Frequency Therapeutics (FREQ), ESSA Pharma (EPIX), Foamix Pharmaceuticals (FOMX), Provention Bio (PRVB), KeyCorp (KEY), RLI (RLI), Encompass Health (EHC), Axon Enterprise (AAXN) and Achillion Pharmaceuticals (ACHN).

Who are ORION OYJ/ADR's key executives?

ORION OYJ/ADR's management team includes the folowing people:
  • Mr. Timo Lappalainen, CEO, Pres & Chairman of the Exec. Management Board (Age 57)
  • Mr. Jari Karlson M.Sc. (Econ.), CFO, Sr. VP of Animal Health & Member of the Exec. Management Board (Age 58)
  • Mr. Olli Huotari, Sr. VP of Corp. Functions, Gen. Counsel, Sec. & Member of Exec. Management Board (Age 53)
  • Mr. Markku Huhta-Koivisto, Sr. VP of Growth Projects & Member of Exec. Management Board (Age 63)
  • Ms. Satu Ahomäki, Sr. VP of Commercial Operations and Member of the Exec. Management Board (Age 53)

How do I buy shares of ORION OYJ/ADR?

Shares of ORINY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is ORION OYJ/ADR's stock price today?

One share of ORINY stock can currently be purchased for approximately $20.78.

How big of a company is ORION OYJ/ADR?

ORION OYJ/ADR has a market capitalization of $5.85 billion and generates $1.15 billion in revenue each year. The company earns $389.97 million in net income (profit) each year or $0.83 on an earnings per share basis. ORION OYJ/ADR employs 3,179 workers across the globe.View Additional Information About ORION OYJ/ADR.

What is ORION OYJ/ADR's official website?

The official website for ORION OYJ/ADR is http://www.orion.fi/.

How can I contact ORION OYJ/ADR?

ORION OYJ/ADR's mailing address is Orionintie 1A, Espoo H9, 02200. The company can be reached via phone at 358 10 4261 or via email at [email protected]


MarketBeat Community Rating for ORION OYJ/ADR (OTCMKTS ORINY)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  89 (Vote Outperform)
Underperform Votes:  118 (Vote Underperform)
Total Votes:  207
MarketBeat's community ratings are surveys of what our community members think about ORION OYJ/ADR and other stocks. Vote "Outperform" if you believe ORINY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ORINY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/17/2020 by MarketBeat.com Staff

Featured Article: What is the S&P/ASX 200 Index?
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel